Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Wanbury Limited ( (IN:WANBURY) ) is now available.
Wanbury Limited has announced the appointment of two new Non-Executive Independent Directors, Mr. Manojkumar Khubchand Gursahani and Mr. Pallavur Sankar Dass Vaidyanathan. Mr. Gursahani will serve a term of one year, while Mr. Vaidyanathan will have a three-year term. This decision, approved in an Extra-Ordinary General Meeting, reflects the company’s efforts to strengthen its board with seasoned professionals. Such appointments could enhance strategic decision-making and governance, potentially impacting the company’s long-term growth and market positioning.
More about Wanbury Limited
Wanbury Limited operates in the pharmaceutical industry, focusing on the production and distribution of pharmaceutical formulations and active pharmaceutical ingredients. The company is headquartered in Navi Mumbai, India, and is engaged in extensive R&D activities to offer a range of healthcare solutions.
YTD Price Performance: -31.08%
Average Trading Volume: 22,718
Current Market Cap: 6.4B INR
See more data about WANBURY stock on TipRanks’ Stock Analysis page.